CNS & Neurological Disorders - Drug Targets
Title:Meet Our Editorial Board Member:
Volume: 14 Issue: 5
Author(s): Claire F. Evans
Affiliation:
Export Options
About this article
Cite this article as:
Evans F. Claire, Meet Our Editorial Board Member:, CNS & Neurological Disorders - Drug Targets 2015; 14 (5) . https://dx.doi.org/10.2174/187152731405150522194720
DOI https://dx.doi.org/10.2174/187152731405150522194720 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
18
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Drugs from the Sea: Conopeptides as Potential Therapeutics
Current Medicinal Chemistry Non-Linear Alteration of Serotonin Transport Availability in Posttraumatic Stress Disorder Measured with 4-[<sup>18</sup>F] ADAM Positron Emission Tomography
Current Molecular Imaging (Discontinued) Erratum
Current Alzheimer Research Chiral Pool/Henry/Enzymatic Routes to Acetogenin Synthons
Letters in Organic Chemistry Natural and Synthetic Inhibitors of Caspases: Targets for Novel Drugs
Current Drug Targets - CNS & Neurological Disorders Clinical Aspects of Melatonin Intervention in Alzheimers Disease Progression
Current Neuropharmacology Long-Term Exposure to Ambient Hydrocarbons Increases Dementia Risk in People Aged 50 Years and above in Taiwan
Current Alzheimer Research G-Protein-Coupled Receptors Oligomerization: Emerging Signaling Units and New Opportunities for Drug Design
Current Protein & Peptide Science Meet Our Editorial Board Member
Combinatorial Chemistry & High Throughput Screening Targeted Therapy of Breast Cancer
Current Pharmaceutical Design The Risk That DSM-5 Will Further Inflate the Diagnostic Bubble
Current Psychiatry Reviews Chemical Senses in Cancer Patients
Current Pharmaceutical Design Dual-target Inhibitors Based on BRD4: Novel Therapeutic Approaches for Cancer
Current Medicinal Chemistry Targeting Apoptosis to Treat Multiple Sclerosis
Current Drug Discovery Technologies Addressing Sexual Acting Out Behaviors with Adolescents on the Autism Spectrum
Adolescent Psychiatry Adulteration Practices of Psychoactive Illicit Drugs: An Updated Review
Current Pharmaceutical Biotechnology The Clinical Impact of ABCB1 Polymorphisms on the Treatment of Psychiatric Diseases
Current Pharmaceutical Design MiR-125b-5p Inhibitor Might Protect Against Sevoflurane-induced Cognitive Impairments by Targeting LIMK1
Current Neurovascular Research Can Decision Making Research Provide a Better Understanding of Chemical and Behavioral Addictions?
Current Drug Abuse Reviews Hotspot Mutations in DICER1 Causing GLOW Syndrome-Associated Macrocephaly <i>via</i> Modulation of Specific microRNA Populations Result in the Activation of PI3K/ATK/mTOR Signaling
MicroRNA